High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma

Head Neck. 2019 Sep;41(9):3317-3327. doi: 10.1002/hed.25842. Epub 2019 Jun 17.

Abstract

Background: To investigate the prognostic value of radiologic extra-nodal extension (rENE) in stage II nasopharyngeal carcinoma (NPC).

Methods: Stage II NPC patients with N1 category (n = 365) were enrolled and divided into three groups according to the situation of rENE: without rENE, suspected rENE, and confirmed rENE (grades: A, infiltration into surrounding fat; B, matted nodes; C, infiltration into adjacent structures).

Results: Only high-grade rENE (including matted nodes and infiltration into adjacent structures) could significantly influence the survival outcomes, patients with high-grade rENE had significantly poorer survival than those without, with the 7-year distant metastasis-free survival and overall survival demonstrated to be 78.5% vs 93.0% (P < .001) and 81.9% vs 89.9% (P = .05), respectively. High-grade rENE, as defined in our study, is a stable criterion, with high intra-rater and inter-rater consistency.

Conclusion: High-grade rENE was an evaluable predictor that could help with the selection of stage II patients with high risk of distant metastasis.

Keywords: intensity-modulated radiation therapy; nasopharyngeal carcinoma; radiologic extra-nodal extension; risk of distant metastasis; stage II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nasopharyngeal Carcinoma / diagnostic imaging*
  • Nasopharyngeal Carcinoma / mortality
  • Nasopharyngeal Carcinoma / secondary*
  • Nasopharyngeal Neoplasms / diagnostic imaging*
  • Nasopharyngeal Neoplasms / mortality
  • Nasopharyngeal Neoplasms / pathology*
  • Neoplasm Grading
  • Neoplasm Staging
  • Observer Variation
  • Predictive Value of Tests
  • Reproducibility of Results
  • Retrospective Studies
  • Survival Rate
  • Young Adult